MetaStar, Inc.

metastar.com

MetaStar is a quality improvement organization with 45 years of experience working alongside those in the health care system to improve the quality of health care for all patients. Our health care improvement and consulting services address the need for system-wide innovation and consistent, evidence-based approaches across all settings of care. All of our work is guided by our mission, to effect positive change in health and health care. We work with communities, providers, and insurers to transform care with a vision of optimal health for all. MetaStar is an independent nonprofit based in Madison and represents Wisconsin in the Lake Superior Quality Innovation Network.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Industrial Impact

LARONDE ATTRACTS $440M IN FIRST EXTERNAL FINANCING TO FURTHER ADVANCE ENDLESS RNA™ PLATFORM

Laronde | August 30, 2021

news image

Laronde, the company pioneering Endless RNA™ a novel, engineered form of RNA that can be programmed to express therapeutic proteins inside the body, today announced that it has raised $440 Million in a Series B Financing to advance the development of its eRNA platform and a broad pipeline of programs across a number of therapeutic categories. The financing round included the company's founder, Flagship Pioneering, along with funds and accounts advised by T. Rowe Price Associates, Inc.,...

Read More

Diagnostics

LUCID DIAGNOSTICS, A SUBSIDIARY OF PAVMED, ANNOUNCED LAUNCH OF VA ESOGUARD® STUDY

Lucid Diagnostics | March 25, 2022

news image

Lucid Diagnostics Inc., a commercial-stage cancer prevention diagnostics company and a majority-owned subsidiary of PAVmed Inc, announced that investigators at the Louis Stokes Cleveland Department of Veterans Affairs Medical Center had enrolled their first patient in a Department of Defense ("DoD")- Katarina B. Greer, M.D., an associate professor of medicine at Case Western Reserve University School of Medicine in Cleveland, is the lead investigator of the research. Lucid supplies the...

Read More

Cell and Gene Therapy

EXACT SCIENCES ACQUIRES PREVENTIONGENETICS TO ACCELERATE AVAILABILITY OF HEREDITARY CANCER TESTING FOR MORE PATIENTS

Exact Sciences Corporation | January 10, 2022

news image

Exact Sciences Corp. announced it has acquired PreventionGenetics, a genetic testing laboratory, to complement its advanced cancer diagnostics portfolio and support its entrance into hereditary cancer testing (HCT). PreventionGenetics provides the clinical lab, expertise, and foundational technology necessary to accelerate the availability of HCT and help more patients know their germline risk of cancer and other diseases. "PreventionGenetics is a natura...

Read More

MEDICINAL GENOMICS ANNOUNCES NEW PATHOSEEK® ASPERGILLUS MULTIPLEX ASSAY TO STREAMLINE CANNABIS TESTING

BioSpace | February 27, 2020

news image

Medicinal Genomics (MGC), a pioneer in harnessing cannabis genomics to improve the agricultural productivity, safety, and transparency of cannabis, today announced its new PathoSEEK® 5-Color Aspergillus Multiplex Assay that independently identifies four species of pathogenic Aspergillus— A. flavus, A. fumigatus, A. niger, and A. terreus — on cannabis samples using just one qPCR reaction. This new Aspergillus assay is the first and only qPCR multiplex that can satisfy the Californ...

Read More
news image

Industrial Impact

LARONDE ATTRACTS $440M IN FIRST EXTERNAL FINANCING TO FURTHER ADVANCE ENDLESS RNA™ PLATFORM

Laronde | August 30, 2021

Laronde, the company pioneering Endless RNA™ a novel, engineered form of RNA that can be programmed to express therapeutic proteins inside the body, today announced that it has raised $440 Million in a Series B Financing to advance the development of its eRNA platform and a broad pipeline of programs across a number of therapeutic categories. The financing round included the company's founder, Flagship Pioneering, along with funds and accounts advised by T. Rowe Price Associates, Inc.,...

Read More
news image

Diagnostics

LUCID DIAGNOSTICS, A SUBSIDIARY OF PAVMED, ANNOUNCED LAUNCH OF VA ESOGUARD® STUDY

Lucid Diagnostics | March 25, 2022

Lucid Diagnostics Inc., a commercial-stage cancer prevention diagnostics company and a majority-owned subsidiary of PAVmed Inc, announced that investigators at the Louis Stokes Cleveland Department of Veterans Affairs Medical Center had enrolled their first patient in a Department of Defense ("DoD")- Katarina B. Greer, M.D., an associate professor of medicine at Case Western Reserve University School of Medicine in Cleveland, is the lead investigator of the research. Lucid supplies the...

Read More
news image

Cell and Gene Therapy

EXACT SCIENCES ACQUIRES PREVENTIONGENETICS TO ACCELERATE AVAILABILITY OF HEREDITARY CANCER TESTING FOR MORE PATIENTS

Exact Sciences Corporation | January 10, 2022

Exact Sciences Corp. announced it has acquired PreventionGenetics, a genetic testing laboratory, to complement its advanced cancer diagnostics portfolio and support its entrance into hereditary cancer testing (HCT). PreventionGenetics provides the clinical lab, expertise, and foundational technology necessary to accelerate the availability of HCT and help more patients know their germline risk of cancer and other diseases. "PreventionGenetics is a natura...

Read More
news image

MEDICINAL GENOMICS ANNOUNCES NEW PATHOSEEK® ASPERGILLUS MULTIPLEX ASSAY TO STREAMLINE CANNABIS TESTING

BioSpace | February 27, 2020

Medicinal Genomics (MGC), a pioneer in harnessing cannabis genomics to improve the agricultural productivity, safety, and transparency of cannabis, today announced its new PathoSEEK® 5-Color Aspergillus Multiplex Assay that independently identifies four species of pathogenic Aspergillus— A. flavus, A. fumigatus, A. niger, and A. terreus — on cannabis samples using just one qPCR reaction. This new Aspergillus assay is the first and only qPCR multiplex that can satisfy the Californ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us